Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 210723

HYDROXYPROGESTERONE CAPROATE (HYDROXYPROGESTERONE CAPROATE)
250MG/ML (250MG/ML) Marketing Status: Prescription

Active Ingredient: HYDROXYPROGESTERONE CAPROATE
Proprietary Name: HYDROXYPROGESTERONE CAPROATE
Dosage Form; Route of Administration: SOLUTION; INTRAMUSCULAR
Strength: 250MG/ML (250MG/ML)
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A210723
Product Number: 001
Approval Date: Jun 21, 2018
Applicant Holder Full Name: LUITPOLD PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English